TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Japan Tissue Engineering Co., Ltd. ( (JP:7774) ).
Japan Tissue Engineering Co., Ltd. reported a decline in financial performance for the fiscal year ended March 31, 2025, with net sales decreasing by 2.3% and a net loss of 255 million yen. Despite the financial downturn, the company maintains a strong equity to total assets ratio of 89.4%, indicating a stable financial position. The company forecasts an improvement in sales and profits for the next fiscal year, reflecting optimism about future growth despite external environmental challenges.
More about Japan Tissue Engineering Co., Ltd.
Japan Tissue Engineering Co., Ltd. operates in the biotechnology industry, focusing on tissue engineering and regenerative medicine. The company’s primary products and services include the development and commercialization of tissue-engineered medical products, aiming to address unmet medical needs and improve patient outcomes.
Average Trading Volume: 300,762
Technical Sentiment Signal: Buy
Current Market Cap: Yen23.35B
Learn more about 7774 stock on TipRanks’ Stock Analysis page.